Cancer-associated fibroblasts at the crossroads of tumor progression and therapy resistance: from heterogeneity to precision reprogramming
Crossref DOI link: https://doi.org/10.1186/s43046-025-00334-7
Published Online: 2025-12-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Adusumalli, Ravi
Banala, Rajkiran Reddy
Text and Data Mining valid from 2025-12-22
Version of Record valid from 2025-12-22
Article History
Received: 1 October 2025
Accepted: 4 November 2025
First Online: 22 December 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.